Pure Global

Efficiency of Spatially Distributed Sequential Stimulation (Sdss) for Functional Electrical Stimulation (FES) of Upper Motor Neuron Syndrome (UMR) Patients - Trial NCT06421753

Access comprehensive clinical trial information for NCT06421753 through Pure Global AI's free database. This phase not specified trial is sponsored by UGECAM Rhône-Alpes and is currently Recruiting. The study focuses on Upper Motor Neuron Disease. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06421753
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.govNCT06421753
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficiency of Spatially Distributed Sequential Stimulation (Sdss) for Functional Electrical Stimulation (FES) of Upper Motor Neuron Syndrome (UMR) Patients

Study Focus

SDSS

Interventional

device

Sponsor & Location

UGECAM Rhône-Alpes

Saint didier au mont d'or, France

Timeline & Enrollment

N/A

May 14, 2024

Dec 31, 2024

10 participants

Primary Outcome

Average quadriceps power output (watts) measured during 3 minutes of FES cycling

Summary

To determine whether Spatially Distributed Sequential Functional Electrical Stimulation is
 more effective than Standard Electrical Stimulation During Functional Electrical Stimulation
 in Upper Motor Neuron Patients

ICD-10 Classifications

Motor neuron disease
Upper motor neuron facial paralysis
Other mononeuropathies of upper limb
Mononeuropathies of upper limb
Mononeuropathy of upper limb, unspecified

Data Source

ClinicalTrials.gov

NCT06421753

Device Trial